Search

HEALIUS LTD

Chiusa

SettoreSettore sanitario

1.02 0.99

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.02

Massimo

1.02

Metriche Chiave

By Trading Economics

Vendite

-14M

682M

Dipendenti

3,699

EBITDA

-91M

85M

Raccomandazioni

By TipRanks

Raccomandazioni

Vendi

Previsioni per 12 mesi

-6.08% downside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

113M

657M

Apertura precedente

0.03

Chiusura precedente

1.02

HEALIUS LTD Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

14 gen 2026, 22:41 UTC

Acquisizioni, Fusioni, Takeovers

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 gen 2026, 00:00 UTC

Utili

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 gen 2026, 23:47 UTC

Discorsi di Mercato

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 gen 2026, 23:44 UTC

Discorsi di Mercato

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 gen 2026, 23:39 UTC

Discorsi di Mercato

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 gen 2026, 23:32 UTC

Discorsi di Mercato

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 gen 2026, 22:56 UTC

Acquisizioni, Fusioni, Takeovers

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 gen 2026, 22:53 UTC

Acquisizioni, Fusioni, Takeovers

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 gen 2026, 22:17 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

14 gen 2026, 22:17 UTC

Discorsi di Mercato

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 gen 2026, 22:09 UTC

Utili

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 gen 2026, 22:08 UTC

Utili

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 gen 2026, 22:08 UTC

Utili

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 gen 2026, 21:53 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 gen 2026, 21:53 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 gen 2026, 21:52 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Announces Positive Profit Alert for 2025

14 gen 2026, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

Citigroup Acting as Financial Advisor to WuXi XDC

14 gen 2026, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 gen 2026, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 gen 2026, 21:50 UTC

Discorsi di Mercato
Utili

Financial Services Roundup: Market Talk

14 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

14 gen 2026, 21:49 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 gen 2026, 21:48 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 gen 2026, 21:48 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Makes Cash Offer for BioDlink International

14 gen 2026, 21:13 UTC

Discorsi di Mercato

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 gen 2026, 20:30 UTC

Discorsi di Mercato
Utili

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 gen 2026, 20:13 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 gen 2026, 20:08 UTC

Discorsi di Mercato

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 gen 2026, 19:33 UTC

Discorsi di Mercato

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 gen 2026, 19:06 UTC

Discorsi di Mercato
Utili

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

HEALIUS LTD Previsione

Obiettivo di Prezzo

By TipRanks

-6.08% in calo

Previsioni per 12 mesi

Media 0.92 AUD  -6.08%

Alto 1.048 AUD

Basso 0.808 AUD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per HEALIUS LTD - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Vendi

2 ratings

0

Acquista

1

Mantieni

1

Vendi

Notizie finanziarie

$

Chi Siamo HEALIUS LTD

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories, medical centers, patient collection centers, and community imaging centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
help-icon Live chat